As the first and only state contracting for its own affordable insulin, Governor Gavin Newsom announced Oct. 16 that CalRx® ...

(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

California Gov. Gavin Newsom listens media questions after announcing CaIRx-branded insulin glargine pens available next Jan.

California is on track to become the first state to sell its own insulin. Santa Barbara County Health Pharmacy ...

Biocon Biologics recently announced that it would manufacture and supply insulin glargine pens to Civica under a multi-year ...

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say ...

California will start selling a generic version of glargine at a recommended price of $11 per pen, or $55 for a five-pack, January 1.

In other news, Lilly announced its investigational oral GLP-1 agent orforglipron outperformed dapagliflozin (Farxiga) for ...

Litigation over Medtronic Plc’s alleged scheme to avoid $100 million in deal payments by sabotaging sales of a reusable ...

The new CalRx insulin will work as a generic version of glargine and could save patients $2,000 to $4,000 per year ...

AI tools designed to make health care more efficient are ubiquitous, though many remain piecemeal and siloed, as researchers ...